Fundamental analysis by بورس24 | Bourse24 about Stock دلقما on 5/13/2023

✅ Shareholders' shareholders are in the process Loghman Pharmaceutical and Health Company said the sales rate of 20 items produced by the company in different groups of drugs increased by 5% to cover the costs of raw material prices based on the Food and Drug Administration's license. 🔗 Read more ... @Bourse24ir